What Is GSK (LSE:GSK) Really Gaining From Its New AI Drug Discovery Deal?

GSK (LSE:GSK) announced a new collaboration with Chai Discovery to apply AI-driven protein design in its drug discovery pipeline. The partnership gives GSK access to Chai…

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)